The therapeutic potential of targeting ACE2 in COVID-19
R. Elmorsi Faculty of Medicine, Mansoura University, Mansoura, Egypt. ramiamjad1@gmail.com
OBJECTIVE: ACE2 long served as the human gateway for multiple coronaviruses, including the currently pandemic SARS-CoV-2. This mini-review explores the potential of targeting ACE2 in blocking viral penetrance.
MATERIALS AND METHODS: PubMed search was conducted using the terms: “coronaviridae”, “peptidyl-dipeptidase A”, “ACE2”, “SARS”, and “SARS-CoV-2”. References of relevant articles were further screened by the author.
RESULTS: Four main methods of blocking ACE2-mediated viral penetrance were identified: receptor blockage, receptor decoying, receptor shedding, and co-receptor inhibition.
CONCLUSIONS: Drugs that inhibit viral binding to ACE2 present a strong choice for the current, and if necessary, future outbreaks. Further research is needed to establish the clinical and pharmacological aspects of the identified candidate molecules.
Free PDF Download
![Creative Commons License](https://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
R. Elmorsi
The therapeutic potential of targeting ACE2 in COVID-19
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 18
Pages: 9744-9747
DOI: 10.26355/eurrev_202009_23067